SCHEMBL17513348

SCHEMBL17513348

CCOC(=O)Cc1cc2cc(Cl)cc(Cl)c2o1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.44
GPR35 Q9HC97 2/20 0.43
USP2 O75604 1/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
CYP19A1 P11511 1/20 0.41
F12 P00748 3/20 0.41
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
ABCB1 P08183 1/20 0.38
TSHR P16473 1/20 0.38
PTGER1 P34995 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19399632 0.84 PTGER1 (0.42) MAOBGPR35USP2POLBHPGD
SCHEMBL19399633 0.79 GPR35 (0.54) GPR35USP2POLBHPGDALOX15
SCHEMBL20799424 0.78 TP53 (0.48) MAOBGPR35HPGDHSD17B10ALDH1A1
SCHEMBL9612675 0.77 MAOB (0.52) MAOBGPR35USP2POLBHPGD
SCHEMBL16595731 0.75 MAOB (0.44) MAOBGPR35USP2POLBHPGD
SCHEMBL11494991 0.74 MAOB (0.77) MAOBGPR35USP2POLBHPGD
SCHEMBL16595729 0.72 MAOB (0.42) MAOBGPR35USP2POLBHPGD
SCHEMBL2167349 0.71 KDM4E (0.44) HPGDCASP1CASP7HSD17B10ALDH1A1
SCHEMBL5947962 0.70 MAOB (0.52) MAOBHPGDHSD17B10ALDH1A1KDM4E
SCHEMBL6367851 0.69 MAPT (0.51) MAOBPOLBHPGDL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016029146-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE UNIVERSITY OF WASHINGTON (US) 2016-02-25 WO claimed
US-10913736-B2 Specific inhibitors of methionyl-tRNA synthetase UNIVERSITY OF WASHINGTON (US) 2021-02-09 US disclosed
US-20170275279-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE UNIVERSITY OF WASHINGTON 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275279-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE AARS1, MTR, GARS1 MAOB 1757/4885GPR35 4475/4885USP2 1834/4885
US-10913736-B2 Specific inhibitors of methionyl-tRNA synthetase AARS1, MTR, GARS1 MAOB 1757/4885GPR35 4475/4885USP2 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.